This website uses cookies to analyse the traffic, to personalise content and ads, and to provide social media features. Our cookie policy provides further information on what cookies are and how we use them, we have also provided details on where you can find out how to disable and delete cookies on your device. By continuing to use this site, you consent to our use of cookies on this device in accordance with our cookie policy.
2021-05-10T10:03:00
NHS England is to roll out a new drug which halves the risk of cancer for patients dealing with a return of the disease after undergoing treatment
Register for free
Already have an account?Sign in